ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
会议论文

Safety, tolerability, and preliminary antitumor activity of sitravatinib plus tislelizumab (TIS) in patients (pts) with unresectable locally advanced or metastatic hepatocellular carcinoma (HCC)

Zhang, Feng; Bai, Yuxian; Fang, Weijia; Meng, Zhiqiang; Xiong, Jianping; Guo, Yabing; Zhang, Tao; Zhang, Jingdong; Ying, Jieer; Chen, Zhendong; Ren, Zhenggang; Chen, Yajin; Hao, Chunyi; Yang, Liu; Wang, Jun; Zhang, Juan; Yu, Fan; Fei, Cong; Wu, Xikun; Qin, Shukui复旦大学; 华中科技大学; 南昌大学; 南方医科大学; 哈尔滨医科大学; 浙江大学; 中国医科大学; 中山大学; 1
ASCO Gastrointestinal Cancers Symposium2022-2-1DOI: 10.1200/JCO.2022.40.4_suppl.418
3被引7阅读
引用收藏
分享
相关
加载中…
  • Phase (Ph) I/II study of sitravatinib (Sitra) alone or with tislelizumab (TIS) in advanced hepatocellular carcinoma (HCC) and gastric/gastroesophageal junction cancer (GC/ GEJC)
    Li, J.; Bai, Y.; Chen, Z.; Ying, J.; Guo, Y.; Fang, W.; Zhang, F.; Xiong, J.; Zhang, T.; Meng, Z.; Zhang, J.; Yu, F.; Zhang, J.; Zhang, Z.; Qin, S.Annual Meeting of the European-Society-for-Medical-Oncology (ESMO), Barcelona, SPAIN, 2023-10-20 To 2023-10-24.
  • Safety, tolerability, and preliminary antitumor activity of sitravatinib plus tislelizumab (TIS) in patients (pts) with unresectable locally advanced or metastatic gastric cancer/gastroesophageal junction cancer (GC/GEJC)
    Chen, Zhendong; Bai, Yuxian; Zhang, Tao; Ying, Jieer; Lin, Xiaoyan; Yang, Liu; Wang, Jun; Zhang, Juan; Yu, Fan; Fei, Cong; Huang, Ruiqi; Li, JinASCO Gastrointestinal Cancers Symposium, San Francisco, CA, 2022-01-20 To 2022-01-22.被引 1
  • Tislelizumab (TIS) versus sorafenib (SOR) in first-line (1L) treatment of unresectable hepatocellular carcinoma (HCC): The RATIONALE-301 Chinese subpopulation analysis
    Qin, S.; Guo, Y.; Meng, Z.; Wu, J.; Gu, K.; Zhang, T.; Lin, X.; Lin, H.; Ying, J-E.; Zhou, F.; Hsing-Tao, K.; Chao, Y.; Li, S.; Chen, Y.; Boisserie, F.; Abdrashitov, R.; Bai, Y.ESMO Asia Congress, Singapore, SINGAPORE, 2022-12-02 To 2022-12-04.被引 1
查看全部 →

会议信息

会议名称
ASCO Gastrointestinal Cancers Symposium
会议日期
2022-01-20 至 2022-01-22
论文集名
JOURNAL OF CLINICAL ONCOLOGY
发表日期
2022-02-01
DOI
10.1200/JCO.2022.40.4_suppl.418
资助标注
BeiGene Ltd.
收录
ISTP · SCIE

作者

  • Z

    Zhang, Feng (第一作者)

  • B

    Bai, Yuxian

查看全部 20 位作者收起作者
  • F

    Fang, Weijia

  • M

    Meng, Zhiqiang

  • X

    Xiong, Jianping

  • G

    Guo, Yabing

  • Z

    Zhang, Tao

  • Z

    Zhang, Jingdong

  • Y

    Ying, Jieer

  • C

    Chen, Zhendong

  • R

    Ren, Zhenggang

  • C

    Chen, Yajin

  • H

    Hao, Chunyi

  • Y

    Yang, Liu

  • W

    Wang, Jun

  • Z

    Zhang, Juan

  • Y

    Yu, Fan

  • F

    Fei, Cong

  • W

    Wu, Xikun

  • Q

    Qin, Shukui

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417